Allayo Adds Biotech Industry Veteran to Board of Directors
PRWeb - Fri Mar 28, 9:05AM CDT
Today Allayo announced the addition of a new member to the company board of directors. Allayo, known for their innovative virtual health assistant app which was acclaimed at HealthBeat 2013 as one of the coolest new apps, provides health care consumers with an easier way to understand and act on their personal health information and assistance in arranging for appointments, prescription refills, lab work, and more. The mobile app provides a single point of coordination for personal health that also lets consumers win gifts and rewards for their healthy behaviors.
Verastem Acquires Rights to Cancer Stem Cell Inhibitor VS-4718
Business Wire - Tue Feb 25, 6:01AM CST
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it has acquired the license to VS-4718 held originally by Poniard Pharmaceuticals. The previous and future developmental, regulatory and commercial royalty milestones and payments associated with the development and potential future sales of VS-4718 due to Poniard Pharmaceuticals are now owned by Verastem. Verastem retains a license to VS-4718 from The Scripps Research Institute.